Posted On: 11/09/2015 8:40:19 AM
Post# of 115
FRISCO, TX--(Marketwired - November 09, 2015) - OxySure Systems, Inc. (OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other innovative medical solutions, today announced that its Board of Directors approved a change of the Company's name to OxySure Therapeutics, Inc.
"The purpose of the name change is to better reflect the business and industry that we are in," said Julian Ross, CEO of OxySure. "It also enhances the Company's positioning as we march towards our Nasdaq uplisting and develop our institutional following," he added.
The Company's ticker symbol will remain the same, OXYS, and the company's website will remain the same, www.oxysure.com.
The name change will become effective upon the Company receiving consent from a majority of the stockholders of OxySure and the filing of an amendment to the Company's articles of incorporation with the Secretary of State in Delaware.
Speaking from the 2015 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in San Antonio, Dr. Joe Chalil, Strategic Advisor for OxySure, stated: "The word therapeutics encapsulates well all the facets of our business, past, present and future. We note in particular that words such as treatment, curative, remedial, restorative, reparative, corrective and health-giving are all associated with therapeutics."
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other innovative medical solutions, today announced that its Board of Directors approved a change of the Company's name to OxySure Therapeutics, Inc. "The purpose of the name change is to better reflect the business and industry that we are in," said Julian Ross, CEO of OxySure. "It also enhances the Company's positioning as we march towards our Nasdaq uplisting and develop our institutional following," he added.
The Company's ticker symbol will remain the same, OXYS, and the company's website will remain the same, www.oxysure.com.
The name change will become effective upon the Company receiving consent from a majority of the stockholders of OxySure and the filing of an amendment to the Company's articles of incorporation with the Secretary of State in Delaware.
Speaking from the 2015 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in San Antonio, Dr. Joe Chalil, Strategic Advisor for OxySure, stated: "The word therapeutics encapsulates well all the facets of our business, past, present and future. We note in particular that words such as treatment, curative, remedial, restorative, reparative, corrective and health-giving are all associated with therapeutics."
(0)
(0)
